A salivary gland biopsy on the lower lip may be considered a safe procedure for diagnosing Sjögren’s syndrome, with relatively few and mild complications, a study found. According to its authors, proper management and follow-up may reduce the risk of complications from the biopsy and help in the recovery…
News
To combat the continued spread of COVID-19 and its Delta variant, Sjögren’s syndrome patients should get a third dose of the Pfizer or Moderna vaccine, the Sjögren’s Foundation has recommended, pursuant to Centers for Disease Control and Prevention (CDC) guidelines. The CDC — the United States’ public…
The Sjögren’s Foundation is calling on runners and walkers to take part in its Team Sjögren’s Training Program for a virtual event that will take place Nov. 25–28. The event will help increase awareness about the autoimmune condition and raise funds for research and education, the foundation announced in…
The findings of a new study support the development of Incyte‘s parsaclisib as a potential therapy for Sjögren’s syndrome and other autoimmune diseases. Parsaclisib, an oral inhibitor of phosphatidylinositol 3-kinase (PI3K) delta, was found to ease the symptoms of Sjögren’s and other disorders in a study using mouse models.
Current studies investigating treatment strategies for children with Sjögren’s syndrome have poor quality evidence for the development of clinical recommendations, a recent study has found. As such, these children are still prescribed medication based on their doctors’ opinions, not on evidence-based treatment recommendations. “Future research is required to guide…
Rituximab safely and effectively treated sudden interstitial lung disease (ILD) in a 49-year-old man with undiagnosed primary Sjögren’s syndrome, a case study shows. This case adds to a growing number of reports and case series showing that rituximab lessens lung involvement in Sjögren’s patients, further supporting the usefulness…
People with obsessive-compulsive disorder, known as OCD, are at an increased risk — more than three times higher than those who don’t have the condition — of developing Sjögren’s syndrome, according to a population-based study in Taiwan. Additionally, among the general population, women and individuals ages 65 and…
From sharing inspirational stories to educating others, supporters are poised to mark World Sjögren’s Day, observed annually on July 23 to raise awareness about the disease. Awareness and education are crucial to increasing the recognition, diagnosis, understanding, and management of Sjögren’s syndrome, a chronic autoimmune disorder that predominantly affects…
A Chinese herbal medication called SS-1 can reduce inflammation and improve saliva flow, likely due to an inhibitory effect on dendritic cells — a component of the innate immune system, according to a recent study in a mouse model of Sjögren’s syndrome. The study, “Effect of…
The number of lymphocytes — a type of immune blood cell — in the salivary glands of the lip could help identify patients with Sjögren’s syndrome who are at increased risk for developing lymphoma, a new study has found. The study, “A biomarker for lymphoma development in Sjogren’s…
Recent Posts
- Sjögren’s symptoms extend far beyond dryness, U.S. survey finds
- Study links anti-Ro antibody patterns to disease features in Sjögren’s
- Global trial of telitacicept for Sjögren’s doses first patient ‘within weeks’
- Patients, advocates working this month to raise awareness of Sjögren’s
- Biotech, US university partner on new ways to speed Sjögren’s diagnosis
- New study links alternative splicing patterns to Sjögren’s severity
- Initial data from trial testing CLN-978 in Sjögren’s expected this year
- Sjögren’s disease may increase risk of certain digestive cancers: Korean study
- Sjögren’s patients face ‘invisible’ symptoms, lack of understanding
- Sjögren’s protein score may help measure salivary gland inflammation